The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Abstract
Many tumour cells have elevated rates of glucose uptake but reduced rates of oxidative phosphorylation. This persistence of high lactate production by tumours in the presence of oxygen, known as aerobic glycolysis, was first noted by Otto Warburg more than 75 yr ago. How tumour cells establish this altered metabolic phenotype and whether it is essential for tumorigenesis is as yet unknown. Here we show that a single switch in a splice isoform of the glycolytic enzyme pyruvate kinase is necessary for the shift in cellular metabolism to aerobic glycolysis and that this promotes tumorigenesis. Tumour cells have been shown to express exclusively the embryonic M2 isoform of pyruvate kinase. Here we use short hairpin RNA to knockdown pyruvate kinase M2 expression in human cancer cell lines and replace it with pyruvate kinase M1. Switching pyruvate kinase expression to the M1 (adult) isoform leads to reversal of the Warburg effect, as judged by reduced lactate production and increased oxygen consumption, and this correlates with a reduced ability to form tumours in nude mouse xenografts. These results demonstrate that M2 expression is necessary for aerobic glycolysis and that this metabolic phenotype provides a selective growth advantage for tumour cells in vivo.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Paradoxically, decreased pyruvate kinase activity is associated with increased aerobic glycolysis, suggesting the activation of pyruvate kinase activity might be a way to target cancer (Christofk et al., 2008).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Christofk et al., 2008
In the citing paper
“Tumor cells engineered to exclusively express the M2 isoform display increased lactate production characteristic of the Warburg effect and gain a growth advantage in vivo over M1-expressing tumors (57).”
From Fueling Immunity: Insights into Metabolism and Lymphocyte Function (2013) · cites this paper as [57]
In the citing paper
“PKM2 promotes the Warburg effect and tumorigenesis (Christofk et al., 2008; Hitosugi et al., 2009).”
From Pyruvate Kinase M2 Is a PHD3-Stimulated Coactivator for Hypoxia-Inducible Factor 1 (2011) · cites this paper as Christofk et al., 2008
In the citing paper
“Current data indicates that PKM2, when highly expressed, exists in an equilibrium of enzymatically inactive pyruvate kinase dimers (or monomers) which can translocate into the nucleus(Christofk et al., 2008; Hitosugi et al., 2009), and enzymatically active tetramers which are retained in the cytosol(Mazurek et al., 2005).”
From Pyruvate kinase M2 regulates Hif-1α activity and IL-1β induction and is a critical determinant of the Warburg effect in LPS-activated macrophages (2015) · cites this paper as Christofk et al., 2008
Citations
Cites
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
Fantin, V. R., St-Pierre, J., & Leder, P. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.023 · Cited by 1,635
Muller, W., Sinn, E., Pattengale, P., Wallace, R., & Leder, P. (1988) · Cell · doi:10.1016/0092-8674(88)90184-5 · Cited by 1,246
Pyruvate kinase M2 is a phosphotyrosine-binding protein
Christofk, H. R., Vander Heiden, M. G., Wu, N., Asara, J. M., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06667 · Cited by 995
Self-citationMajumder, P. K., Febbo, P. G., Bikoff, R., Berger, R., Xue, Q., McMahon, L. M., Manola, J., Brugarolas, J., McDonnell, T. J., Golub, T. R., et al. (2004) · Nature Medicine · doi:10.1038/nm1052 · Cited by 964
Pyruvate kinase type M2 and its role in tumor growth and spreading
Mazurek, S., Boschek, C. B., Hugo, F., & Eigenbrodt, E. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.04.009 · Cited by 812
Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes
Altenberg, B., & Greulich, K. O. (2004) · Genomics · doi:10.1016/j.ygeno.2004.08.010 · Cited by 662
Growth factors can influence cell growth and survival through effects on glucose metabolism
Vander Heiden, M. G., Plas, D. R., Rathmell, J. C., Fox, C. J., Harris, M. H., & Thompson, C. B. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.17.5899-5912.2001 · Cited by 536
Self-citation
Cited by
Sorted by citations
Items 601–700 of 1,008
Regulatory circuit of PKM2/NF-κB/miR-148a/152-modulated tumor angiogenesis and cancer progression
Xu, Q., Liu, L.-Z., Yin, Y., He, J., Li, Q., Qian, X., You, Y., Lu, Z., Peiper, S. C., Shu, Y., et al. (2015) · Oncogene · doi:10.1038/onc.2015.6 · Cited by 112
Insulin and mTOR Pathway Regulate HDAC3-Mediated Deacetylation and Activation of PGK1
Wang, S., Jiang, B., Zhang, T., Liu, L., Wang, Y., Wang, Y., Chen, X., Lin, H., Zhou, L., Xia, Y., et al. (2015) · PLoS Biology · doi:10.1371/journal.pbio.1002243 · Cited by 112
Gershon, T. R., Crowther, A., Tikunov, A. P., García, I., Annis, R. P., Yuan, H., Miller, C. R., Macdonald, J. M., Olson, J. M., & Deshmukh, M. (2013) · Cancer & Metabolism · doi:10.1186/2049-3002-1-2 · Cited by 113
The tumor suppressor function of mitochondria: Translation into the clinics
Cuezva, J. M., Ortega, A. D., Willers, I. M., Sánchez-Cenizo, L., Aldea, M., & Sánchez‐Aragó, M. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.01.006 · Cited by 111
Colvin, H. S., Nishida, N., Konno, M., Haraguchi, N., Takahashi, H., Nishimura, J., Hata, T., Kawamoto, K., Asai, A., Tsunekuni, K., et al. (2016) · Scientific Reports · doi:10.1038/srep36289 · Cited by 111
Grüning, N., Du, D., Keller, M. A., Luisi, B. F., & Ralser, M. (2014) · Open Biology · doi:10.1098/rsob.130232 · Cited by 109
Sugiyama, T., Taniguchi, K., Matsuhashi, N., Tajirika, T., Futamura, M., Takai, T., Akao, Y., & Yoshida, K. (2016) · Cancer Science · doi:10.1111/cas.13091 · Cited by 109
Targeting the miR-122/PKM2 autophagy axis relieves arsenic stress
Wang, Y., Zhao, H., Guo, M., Fei, D., Zhang, L., & Xing, M. (2019) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2019.121217 · Cited by 109
Could ketogenic diet “starve” cancer? Emerging evidence
Barrea, L., Caprio, M., Tuccinardi, D., Moriconi, E., Renzo, L. D., Muscogiuri, G., Colao, A., Savastano, S., & on behalf of the Obesity Programs of nutrition, E. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1847030 · Cited by 109
Qiu, P., Zhou, Y., Oyang, L., Wu, N., Tang, Y., Su, M., Luo, X., Wang, Y., Sheng, X., Ma, J., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.11.010 · Cited by 109
Targeting glucose metabolism in patients with cancer
Elf, S., & Chen, J. (2013) · Cancer · doi:10.1002/cncr.28501 · Cited by 108
pH-Responsive Self-Assembling Peptide-Based Biomaterials: Designs and Applications
Li, Z., Zhu, Y., & Matson, J. B. (2022) · ACS Applied Bio Materials · doi:10.1021/acsabm.2c00188 · Cited by 108
Furtado, C. M., Marcondes, M. C., Sola‐Penna, M., de Souza, M. L. S., & Zancan, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030462 · Cited by 108
Stimuli responsive drug delivery application of polymer and silica in biomedicine
Gulzar, A., Gai, S., Yang, P., Li, C., Ansari, M. B., & Lin, J. (2015) · Journal of Materials Chemistry B · doi:10.1039/c5tb00757g · Cited by 107
The emerging roles of microRNAs in cancer metabolism
Chan, B., Manley, J., Lee, J., & Singh, S. R. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.10.011 · Cited by 107
Vitting‐Seerup, K., Porse, B. T., Sandelin, A., & Waage, J. (2014) · BMC Bioinformatics · doi:10.1186/1471-2105-15-81 · Cited by 107
Alternative Splicing as a Target for Cancer Treatment
Martínez-Montiel, N., Rosas-Murrieta, N. H., Anaya-Ruíz, M., Monjaraz-Guzmán, E., & Martínez-Contreras, R. D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020545 · Cited by 107
The Warburg Effect in Diabetic Kidney Disease
Zhang, G., Darshi, M., & Sharma, K. (2018) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2018.01.002 · Cited by 107
Aberrant alternative splicing in breast cancer
Yang, Q., Zhao, J., Zhang, W., Chen, D., & Wang, Y. (2019) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjz033 · Cited by 107
Liu, W.-R., Tian, M., Yang, L., Lin, Y., Jin, L., Ding, Z., Shen, Y., Peng, Y., Gao, D., Zhou, J., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2749 · Cited by 107
Applications of metabolomics in cancer research
Styczynski, M. P., & Vermeersch, K. A. (2013) · Journal of Carcinogenesis · doi:10.4103/1477-3163.113622 · Cited by 107
Chang, H. T., Olson, L. K., & Schwartz, K. A. (2013) · Nutrition & Metabolism · doi:10.1186/1743-7075-10-47 · Cited by 107
Metabolic control of the cell cycle
Kalucka, J. M., Missiaen, R., Γεωργιάδου, Μ., Schoors, S., Lange, C. M., Bock, K. D., Dewerchin, M. A., & Carmeliet, P. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1090068 · Cited by 107
Kim, H., Jang, H., Kim, T. W., Kang, B.-H., Lee, S. E., Jeon, Y. K., Chung, D. H., Choi, J., Shin, J., Cho, E., et al. (2015) · Stem Cells · doi:10.1002/stem.2073 · Cited by 106
Self-referenced RGB colour imaging of intracellular oxygen
Wang, X., Gorris, H. H., Stolwijk, J. A., Meier, R. J., Groegel, D. B. M., Wegener, J., & Wolfbeis, O. S. (2011) · Chemical Science · doi:10.1039/c0sc00610f · Cited by 106
Zhou, C., Li, X., Sun, H., Zhang, B., Han, Y., Jiang, Y., Zhuang, Q., Fang, J. S., & Wu, G. (2012) · IUBMB Life · doi:10.1002/iub.1066 · Cited by 106
Lee, S. M., Kim, J., Cho, E., & Youn, H. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.5 · Cited by 106
Martin, S. P., Fako, V. E., Dang, H. T., Dominguez, D. A., Khatib, S. A., Ma, L., Wang, H., Zheng, W., & Wang, X. W. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01605-y · Cited by 105
Tammaro, A., Kers, J., Scantlebery, A. M. L., & Florquin, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01346 · Cited by 105
Synthetic oligonucleotides recruit ILF2/3 to RNA transcripts to modulate splicing
Rigo, F., Hua, Y., Chun, S. J., Prakash, T. P., Krainer, A. R., & Bennett, C. F. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.939 · Cited by 104
Protein kinase function of pyruvate kinase M2 and cancer
Chen, X., Chen, S., & Yu, D. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01612-1 · Cited by 104
Linking vitamin B1 with cancer cell metabolism
Zastre, J. A., Sweet, R. L., Hanberry, B. S., & Ye, S. (2013) · Cancer & Metabolism · doi:10.1186/2049-3002-1-16 · Cited by 103
Iqbal, M. A., & Bamezai, R. N. K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036764 · Cited by 103
He, X., Arslan, A. D., Ho, T.-T., Yuan, C., Stampfer, M. R., & Beck, W. T. (2014) · Oncogenesis · doi:10.1038/oncsis.2013.47 · Cited by 103
Stenmark, K. R., Tuder, R. M., & Kasmi, K. C. E. (2015) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00283.2015 · Cited by 103
Cancer cell metabolism and the modulating effects of nitric oxide
Chang, C.-F., Diers, A. R., & Hogg, N. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.11.012 · Cited by 103
Wu, S., Yun, J., Tang, W., Familiari, G., Relucenti, M., Wu, J., Li, X., Chen, H., & Chen, R. (2023) · ACS Nano · doi:10.1021/acsnano.3c03050 · Cited by 102
Cancer Metabolism: Fueling More than Just Growth
Lee, N., & Kim, D. (2016) · Molecules and Cells · doi:10.14348/molcells.2016.0310 · Cited by 102
Hu, X., Chao, M., & Wu, H. (2017) · Signal Transduction and Targeted Therapy · doi:10.1038/sigtrans.2016.47 · Cited by 102
Zhou, Z., Li, M., Zhang, L., Zhao, H., Şahin, Ö., Chen, J., Zhao, J. J., Songyang, Z., & Yu, D. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-2726 · Cited by 102
Regulations of Glycolytic Activities on Macrophages Functions in Tumor and Infectious Inflammation
Yu, Q., Wang, Y., Lin, D., He, Y., Liu, R., Yang, Q., Cao, Y., Wang, Y., Jia, A., Bi, Y., et al. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00287 · Cited by 102
Two-way communication between the metabolic and cell cycle machineries: the molecular basis
Kaplon, J., van Dam, L., & Peeper, D. S. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1044172 · Cited by 102
Metabolism in cancer metastasis
Weber, G. F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29839 · Cited by 102
PKM2 is involved in neuropathic pain by regulating ERK and STAT3 activation in rat spinal cord
Wang, B., Liu, S. J., Fan, B., Xu, X., Chen, Y., Lu, R., Xu, Z., & Liu, X. (2018) · The Journal of Headache and Pain · doi:10.1186/s10194-018-0836-4 · Cited by 101
Chang, Y., Chiou, J., Yang, Y.-F., Su, C., Lin, Y., Yang, C.-N., Lu, P., Huang, M., Yang, C.-J., & Hsiao, M. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-4080 · Cited by 101
The long noncoding RNA glycoLINC assembles a lower glycolytic metabolon to promote glycolysis
Zhu, Y., Jin, L., Shi, R., Li, J., Wang, Y., Zhang, L., chao-zhao, L., Narayana, V. K., Souza, D. P. D., Thorne, R. F., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2021.11.017 · Cited by 101
Tumor suppressor p53 negatively regulates glycolysis stimulated by hypoxia through its target RRAD
Zhang, C., Liu, J., Wu, R., Liang, Y., 林美华, Liu, J., Chan, C. S., Hu, W., & Feng, Z. (2014) · Oncotarget · doi:10.18632/oncotarget.2137 · Cited by 101
Global Impact of Oncogenic Src on a Phosphotyrosine Proteome
Luo, W., Slebos, R. J. C., Hill, S., Li, M., Brábek, J., Amanchy, R., Chaerkady, R., Pandey, A., Ham, A. L., & Hanks, S. K. (2008) · Journal of Proteome Research · doi:10.1021/pr800187n · Cited by 101
Shalviri, A., Raval, G., Prasad, P., Chan, C., Liu, Q., Heerklotz, H. H., Rauth, A. M., & Wu, X. Y. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.09.001 · Cited by 101
Ma, T., Patel, H., Babapoor-Farrokhran, S., FRANKLIN, R. B., Semenza, G. L., Sodhi, A., & Montaner, S. (2015) · Angiogenesis · doi:10.1007/s10456-015-9475-4 · Cited by 101
Esaki, K., Sayano, T., Sonoda, C., Akagi, T., Suzuki, T., Ogawa, T., Okamoto, M., Yoshikawa, T., Hirabayashi, Y., & Furuya, S. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.603860 · Cited by 100
Diabetes and Cancer—An AACE/ACE Consensus Statement
Handelsman, Y., LeRoith, D., Bloomgarden, Z. T., Dagogo-Jack, S. E., EINHORN, D. F., Garber, A. J., Grunberger, G., Harrell, R. M., Gagel, R. F., Lebovitz, H. E., et al. (2013) · Endocrine Practice · doi:10.4158/ep13248.cs · Cited by 100
Xie, R., Chen, X., Chen, Z., Huang, M. X., Dong, W., Gu, P., Zhang, J., Zhou, Q., Dong, W., Han, J., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.01.041 · Cited by 100
Xia, Q., Jia, J., Hu, C., Lu, J., Li, J., Xu, H., Fang, J., Feng, D., Wang, L., & Chen, Y. (2021) · Oncogene · doi:10.1038/s41388-021-02133-5 · Cited by 100
Ihara, Y., Kihara, Y., Hamano, F., Yanagida, K., Morishita, Y., Kunita, A., Yamori, T., Fukayama, M., Aburatani, H., Shimizu, T., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001165107 · Cited by 100
Efficacy of RNAi targeting of pyruvate kinase M2 combined with cisplatin in a lung cancer model
Guo, W., Zhang, Y., Chen, T., Wang, Y., Xue, J., Zhang, Y., Xiao, W., Mo, X., & Lü, Y. (2010) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-010-0860-5 · Cited by 99
Functions of BCL-X L at the Interface between Cell Death and Metabolism
Michels, J., Kepp, O., Senovilla, L., Lissa, D., Castedo, M., Kroemer, G., & Galluzzi, L. (2013) · International Journal of Cell Biology · doi:10.1155/2013/705294 · Cited by 99
TOR and ageing: a complex pathway for a complex process
McCormick, M. A., Tsai, S., & Kennedy, B. K. (2010) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2010.0198 · Cited by 99
Metabolomics, metabolic flux analysis and cancer pharmacology
Liang, L., Sun, F., Wang, H., & Hu, Z. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107827 · Cited by 99
Mitochondrial Dysfunction as a Hallmark of Environmental Injury
Tête, A., Brial, F., Benoit, L., Koual, M., Tomkiewicz, C., Kim, M. J., Blanc, É., Coumoul, X., & Bortoli, S. (2021) · Cells · doi:10.3390/cells11010110 · Cited by 99
Noninvasive Metabolic Profiling Using Microfluidics for Analysis of Single Preimplantation Embryos
Urbanski, J. P., Johnson, M. T., Craig, D. D., Potter, D. L., Gardner, D. K., & Thorsen, T. (2008) · Analytical Chemistry · doi:10.1021/ac8010473 · Cited by 99
Clinical significance of T cell metabolic reprogramming in cancer
Herbel, C., Patsoukis, N., Bardhan, K., Seth, P., Weaver, J. D., & Boussiotis, V. A. (2016) · Clinical and Translational Medicine · doi:10.1186/s40169-016-0110-9 · Cited by 99
Shan, S., Shi, J., Yang, P., Jia, B., Wu, H., Zhang, X., & Li, Z. (2017) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.7b02757 · Cited by 98
Oct1 loss of function induces a coordinate metabolic shift that opposes tumorigenicity
Shakya, A., Cooksey, R. C., Cox, J. E., Wang, V. E. H., McClain, D. A., & Tantin, D. R. (2009) · Nature Cell Biology · doi:10.1038/ncb1840 · Cited by 97
Tang, R., Yang, C., Ma, X., Wang, Y., Luo, D., Huang, C., Xu, Z., Liu, P., & Yang, L. (2016) · Oncotarget · doi:10.18632/oncotarget.6821 · Cited by 97
Qi, H., Ning, X., Yu, C., Ji, X., Jin, Y., McNutt, M. A., & Yin, Y. (2019) · Cell Death and Disease · doi:10.1038/s41419-018-1271-9 · Cited by 97
Loss of LUC7L2 and U1 snRNP subunits shifts energy metabolism from glycolysis to OXPHOS
Jourdain, A. A., Begg, B. E., Mick, E., Shah, H., Calvo, S. E., Skinner, O. S., Sharma, R., Blue, S. M., Yeo, G. W.-M., Burge, C. B., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.02.033 · Cited by 97
Kong, B., Michalski, C. W., Hong, X., Valkovskaya, N., Rieder, S., Abiatari, I., Streit, S., Erkan, M., Esposito, I., Friess, H., et al. (2010) · Oncogene · doi:10.1038/onc.2010.258 · Cited by 97
Jara, J. A., Castro-Castillo, V., Saavedra‐Olavarría, J., Peredo-Silva, L., Pavani, M., Jaña, F., Letelier, M. E., Parra, E., Becker, M. I., Morello, A., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500174v · Cited by 97
Alternative RNA splicing and cancer
Liu, S., & Cheng, C. (2013) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1178 · Cited by 96
Dai, S., Peng, Y., Zhu, Y., Xu, D., Zhu, F., Xu, W., Chen, Q., Zhu, X., Liu, T., Hou, C., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109521 · Cited by 96
Modulation of redox homeostasis: A strategy to overcome cancer drug resistance
Yang, L., Zhang, X., Wang, Z., Li, B., & Zhu, H. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1156538 · Cited by 96
Discovery of biomarkers for gastric cancer: A proteomics approach
Lin, L., Huang, H., & Juan, H. (2012) · Journal of Proteomics · doi:10.1016/j.jprot.2012.03.046 · Cited by 96
Manganese Superoxide Dismutase in Cancer Prevention
Robbins, D. F., & Zhao, Y. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5297 · Cited by 96
Wu, H., Wang, Y., Wu, C., Yang, P., Li, H., & Li, Z. (2016) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.6b04549 · Cited by 96
Zhao, D., Badur, M. G., Luebeck, J., Magaña, J. H., Birmingham, A., Šášik, R., Ahn, C. S., Ideker, T., Metallo, C. M., & Mali, P. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.01.017 · Cited by 96
Spoden, G. A., Rostek, U., Lechner, S. G., Mitterberger, M. C., Mazurek, S., & Zwerschke, W. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.06.024 · Cited by 95
The Role of PKM2 in Metabolic Reprogramming: Insights into the Regulatory Roles of Non-Coding RNAs
Puckett, D. L., Alquraishi, M. I., Chowanadisai, W., & Bettaieb, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031171 · Cited by 95
Zhou, W., Yang, H.-L., Mei, J., Chang, K., Han, L., Lai, Z., Shi, J., Wang, X., Wu, K., Zhang, T., et al. (2022) · Science Advances · doi:10.1126/sciadv.abj2488 · Cited by 95
Matsuda, S., Adachi, J., Ihara, M., Tanuma, N., Shima, H., Kakizuka, A., Ikura, M., Ikura, T., & Matsuda, T. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv967 · Cited by 95
Aerobic glycolysis: a novel target in kidney cancer
Shuch, B. M., Linehan, W. M., & Srinivasan, R. (2013) · Expert Review of Anticancer Therapy · doi:10.1586/era.13.57 · Cited by 95
He, J., Xie, G., Tong, J., Peng, Y., Haihui, H., Li, J., Wang, N., & Liang, H. (2014) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-014-0062-x · Cited by 95
The PI(3,5)P2 and PI(4,5)P2 Interactomes
Catimel, B., Schieber, C., Condron, M. M., Patsiouras, H., Connolly, L., Catimel, J., Nice, E. C., Burgess, A. W., & Holmes, A. B. (2008) · Journal of Proteome Research · doi:10.1021/pr800540h · Cited by 96
Glycolysis in preimplantation development is partially controlled by the Warburg Effect
Redel, B. K., Brown, A. N., Spate, L. D., Whitworth, K. M., Green, J. A., & Prather, R. S. (2011) · Molecular Reproduction and Development · doi:10.1002/mrd.22017 · Cited by 95
Longen, S., Richter, F. M., Köhler, Y., Wittig, I., Beck, K., & Pfeilschifter, J. M. (2016) · Scientific Reports · doi:10.1038/srep29808 · Cited by 95
Prognostic role of glycolysis for cancer outcome: evidence from 86 studies
Yu, M., Chen, S., Hong, W., Gu, Y., Huang, B., Lin, Y., Zhou, Y., Jin, H., Deng, Y., Tu, L., et al. (2019) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-019-02847-w · Cited by 94
Mitochondrial dysfunction: a neglected component of skin diseases
Feichtinger, R. G., Sperl, W., Bauer, J. W., & Kofler, B. (2014) · Experimental Dermatology · doi:10.1111/exd.12484 · Cited by 94
Tejedor, J. R., Papasaikas, P., & Valcárcel, J. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.10.029 · Cited by 94
Serum Markers of Intrahepatic Cholangiocarcinoma
Malaguarnera, G., Paladina, I., Giordano, M., Malaguarnera, M., Bertino, G., & Berretta, M. (2013) · Disease Markers · doi:10.1155/2013/196412 · Cited by 94
Estèves, P., Pecqueur, C., Ransy, C., Esnous, C., Lenoir, V., Bouillaud, F., Bulteau, A., Lombès, A., Prip‐Buus, C., Ricquier, D., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3383 · Cited by 93
Mossenta, M., Busato, D., Bo, M. D., & Toffoli, G. (2020) · Cancers · doi:10.3390/cancers12061668 · Cited by 93
PKM2 Drives Hepatocellular Carcinoma Progression by Inducing Immunosuppressive Microenvironment
Li, T., Wang, S., Shen, X., Zhang, Z., Chen, M., Wang, H., Zhu, Y., Xu, D., Hu, B., Wei, R., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.589997 · Cited by 93
Self-citationBakhtiyari, M., Liaghat, M., Aziziyan, F., Shapourian, H., Yahyazadeh, S., Alipour, M., Shahveh, S., Maleki‐Sheikhabadi, F., Halimi, H., Forghaniesfidvajani, R., et al. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01282-2 · Cited by 93
The Drosophila TNF ortholog Eiger: Emerging physiological roles and evolution of the TNF system
Igaki, T., & Miura, M. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.05.003 · Cited by 93
Pyruvate Kinase M2 in Blood Circulation Facilitates Tumor Growth by Promoting Angiogenesis
Li, L., Zhang, Y., Qiao, J., Yang, J. J., & Liu, Z. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.576934 · Cited by 93
Phosphotyrosine recognition domains: the typical, the atypical and the versatile
Kaneko, T., Joshi, R., Feller, S. M., & Li, S. S. ‐. (2012) · Cell Communication and Signaling · doi:10.1186/1478-811x-10-32 · Cited by 93
Mohammad, G. H., Damink, S. W. M. O., Malagó, M., Dhar, D. K., & Pereira, S. P. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151635 · Cited by 93
Warburg effect hypothesis in autism Spectrum disorders
Vallée, A., & Vallée, J.-N. (2018) · Molecular Brain · doi:10.1186/s13041-017-0343-6 · Cited by 92
Isotopically nonstationary 13C flux analysis of Myc-induced metabolic reprogramming in B-cells
Murphy, T. A., Dang, C. V., & Young, J. D. (2012) · Metabolic Engineering · doi:10.1016/j.ymben.2012.07.008 · Cited by 92
Mattè, A., Federti, E., Kung, C. K.-H., Kosinski, P. A., Narayanaswamy, R., Russo, R., Federico, G., Carlomagno, F., Desbats, M. A., Salviati, L., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci144206 · Cited by 92
Metadata
- Authors
- Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C.
- Affiliations
- Harvard University (US)
- Boston Children's Hospital (US)
- Broad Institute (US)
- Beth Israel Deaconess Medical Center (US)
- Corresponding author
- Cantley, Lewis C.
- ORCID
- Venue
- Nature
- Published
- 2008-03
- Volume
- 452
- Issue
- 7184
- Pages
- 230-233
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2015207840
- Cited by
- 2,820
- References
- 20
- Citations by year
- 2026: 68 · 2025: 101 · 2024: 133 · 2023: 142 · 2022: 151 · 2021: 174 · 2020: 169 · 2019: 170 · 2018: 190 · 2017: 158 · 2016: 180 · 2015: 204 · 2014: 211 · 2013: 187 · 2012: 186
- FWCI
- 44.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Cancer Institute (T32CA009172)
- National Institute of General Medical Sciences (R01GM056203)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer and biochemical research
- Keywords
- PKM2, alternative splicing, cancer metabolism, Warburg effect, aerobic glycolysis, carcinogenesis, phosphotyrosine binding, lactic acid production, oxygen consumption, glucose uptake, oxidative phosphorylation, tumor growth, glycolysis, tumor cell proliferation, tumor hypoxia
- MeSH terms
- Animals, Fructosediphosphates, Glycolysis, Humans, Lung Neoplasms, Male, Mice, Nude, Neoplasm Transplantation, Neoplasms, Oxidative Phosphorylation, Oxygen Consumption, Pyruvate Kinase, Gene Expression Regulation, Neoplastic, Alternative Splicing, Pyruvic Acid, Lactic Acid, Cell Line, Tumor, Cell Proliferation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
